Robert Janssen
2017
In 2017, Robert Janssen earned a total compensation of $1.7M as Chief Medical Officer and Senior Vice President, Clinical Development, Medical and Regulatory Affairs at Dynavax Technologies, a 61% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $260,000 |
|---|---|
| Salary | $400,000 |
| Stock Awards | $1,068,056 |
| Other | $2,000 |
| Total | $1,730,056 |
Janssen received $1.1M in stock awards, accounting for 62% of the total pay in 2017.
Janssen also received $260K in non-equity incentive plan, $400K in salary and $2K in other compensation.
Rankings
In 2017, Robert Janssen's compensation ranked 6,223rd out of 14,666 executives tracked by ExecPay. In other words, Janssen earned more than 57.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,223 out of 14,666 | 58th |
Division Manufacturing | 2,287 out of 5,768 | 60th |
Major group Chemicals And Allied Products | 725 out of 2,074 | 65th |
Industry group Drugs | 561 out of 1,730 | 68th |
Industry Pharmaceutical Preparations | 442 out of 1,329 | 67th |
Source: SEC filing on April 20, 2018.
Janssen's colleagues
We found four more compensation records of executives who worked with Robert Janssen at Dynavax Technologies in 2017.